GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BPH Global Ltd (ASX:BP8) » Definitions » Loans Receivable

BPH Global (ASX:BP8) Loans Receivable : A$0.00 Mil (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is BPH Global Loans Receivable?

BPH Global's Loans Receivable for the quarter that ended in Dec. 2023 was A$0.00 Mil.


BPH Global Loans Receivable Historical Data

The historical data trend for BPH Global's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BPH Global Loans Receivable Chart

BPH Global Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

BPH Global Semi-Annual Data
Dec07 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

BPH Global Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


BPH Global Loans Receivable Related Terms

Thank you for viewing the detailed overview of BPH Global's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


BPH Global (ASX:BP8) Business Description

Traded in Other Exchanges
N/A
Address
96 Elizabeth Street, Block Arcade, Office 324, Level 3, Melbourne, VIC, AUS, 3000
BPH Global Ltd, formerly Stemcell United Ltd is a marine and agricultural biotechnology industry. Its only operating segment is sourcing, producing, marketing, and selling traditional medicines. The company's geographical segment includes Australia; Singapore; Malaysia and Greater China. The company's product comprises Cannabis sativa; Dendrobium Officinale and Daemonorops Draco Blume.

BPH Global (ASX:BP8) Headlines

No Headlines